Kusajili – Centralise les essais cliniques mondiaux

A single center open-label uncontrolled study to investigate the PSA and tumor vascularization response rate of neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable pros...

Mise à jour : Il y a 4 ans
Référence :

A single center open-label uncontrolled study to investigate the PSA and tumor vascularization response rate of neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable prostate cancer

| Pays :
The Netherlands
| Organes :
| Spécialités :

Extrait

Critère d'inclusion

Prostate cancer

Liens

ictrp